Literature DB >> 29192305

Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer.

Allen S Ho1,2, Sungjin Kim1,3, Mourad Tighiouart1,3, Cynthia Gudino1, Alain Mita1,4, Kevin S Scher1,4, Anna Laury1,5, Ravi Prasad1,6, Stephen L Shiao1,7, Nabilah Ali1,2, Chrysanta Patio1,2, Jon Mallen-St Clair1,2, Jennifer E Van Eyk1,8, Zachary S Zumsteg1,7.   

Abstract

Importance: Nodal staging for laryngohypopharyngeal cancers is based primarily on size and laterality, with less value placed on absolute number of metastatic lymph nodes (LNs). We are aware of no studies to date that have specifically addressed the prognostic effect of quantitative nodal burden in larynx or hypopharynx malignancies. Objective: To assess the independent impact of quantitative metastatic LN burden on mortality risk. Design, Setting, and Participants: Univariate and multivariable models were constructed to evaluate the association between patients' number of metastatic LNs and their survival, adjusting for factors such as nodal size, laterality, extranodal extension, margin status, and adjuvant treatment. Participants were patients with squamous cell carcinoma of the larynx or hypopharynx undergoing upfront surgical resection for curative intent at a US hospital between 2004 and 2013, as identified in the National Cancer Database. A neck dissection of a minimum of 10 LNs was required. Main Outcomes and Measures: Overall survival.
Results: Overall, 8351 cases were included (mean [SD] age, 61 [10.1] years; 6499 men [77.8%]; 4710 patients with metastatic LNs and 3641 with no metastatic LNs). Mortality risk escalated continuously without plateau as number of metastatic nodes increased, with the hazard per node (hazard ratio [HR], 1.19; 95% CI, 1.16-1.23; P < .001) most pronounced up to 5 positive LNs. Extranodal extension was also associated with increased mortality (HR, 1.34; 95% CI, 1.13-1.59; P < .001). Increasing number of nodes examined was associated with improved survival, albeit to a lesser degree (per 10 LNs: HR, 0.97; 95% CI, 0.96-0.98; P < .001) and without a detectable change point. Other nodal factors, including nodal size, contralateral LN involvement (TNM stage N2c), and lower LN involvement (levels 4-5), were not associated with mortality in multivariable models when accounting for number of positive LNs. A novel, parsimonious nodal staging system derived by recursive partitioning analysis exhibited greater concordance with survival than the TNM staging system outlined in the American Joint Committee on Cancer's AJCC Staging Manual, 8th edition. Conclusions and Relevance: The number of metastatic nodes is a predominant independent factor associated with mortality in hypopharyngeal and laryngeal cancers. Moreover, standard nodal staging factors like LN size and contralaterality have no independent prognostic value when accounting for positive LN number. Deeper integration of quantitative metastatic nodal disease may simplify staging and better triage the need for adjuvant therapy.

Entities:  

Mesh:

Year:  2018        PMID: 29192305      PMCID: PMC6584272          DOI: 10.1001/jamaoncol.2017.3852

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  11 in total

1.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Authors:  Arlene A Forastiere; Helmuth Goepfert; Moshe Maor; Thomas F Pajak; Randal Weber; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Clifford Chao; Glen Peters; Ding-Jen Lee; Andrea Leaf; John Ensley; Jay Cooper
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

2.  Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.

Authors:  Guillaume Janoray; Yoann Pointreau; Pascal Garaud; Sophie Chapet; Marc Alfonsi; Christian Sire; Eric Jadaud; Gilles Calais
Journal:  J Natl Cancer Inst       Date:  2015-12-16       Impact factor: 13.506

3.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

Authors:  J L Lefebvre; D Chevalier; B Luboinski; A Kirkpatrick; L Collette; T Sahmoud
Journal:  J Natl Cancer Inst       Date:  1996-07-03       Impact factor: 13.506

4.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

5.  Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

Authors:  Brian O'Sullivan; Shao Hui Huang; Jie Su; Adam S Garden; Erich M Sturgis; Kristina Dahlstrom; Nancy Lee; Nadeem Riaz; Xin Pei; Shlomo A Koyfman; David Adelstein; Brian B Burkey; Jeppe Friborg; Claus A Kristensen; Anita B Gothelf; Frank Hoebers; Bernd Kremer; Ernst-Jan Speel; Daniel W Bowles; David Raben; Sana D Karam; Eugene Yu; Wei Xu
Journal:  Lancet Oncol       Date:  2016-02-27       Impact factor: 41.316

6.  NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Authors:  David Adelstein; Maura L Gillison; David G Pfister; Sharon Spencer; Douglas Adkins; David M Brizel; Barbara Burtness; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; A Dimitrios Colevas; David W Eisele; Moon Fenton; Robert L Foote; Jill Gilbert; Robert I Haddad; Wesley L Hicks; Ying J Hitchcock; Antonio Jimeno; Debra Leizman; William M Lydiatt; Ellie Maghami; Loren K Mell; Bharat B Mittal; Harlan A Pinto; John A Ridge; James Rocco; Cristina P Rodriguez; Jatin P Shah; Randal S Weber; Matthew Witek; Frank Worden; Sue S Yom; Weining Zhen; Jennifer L Burns; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-06       Impact factor: 11.908

7.  Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

Authors:  William M Lydiatt; Snehal G Patel; Brian O'Sullivan; Margaret S Brandwein; John A Ridge; Jocelyn C Migliacci; Ashley M Loomis; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2017-01-27       Impact factor: 508.702

8.  Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.

Authors:  J-L Lefebvre; G Andry; D Chevalier; B Luboinski; L Collette; L Traissac; D de Raucourt; J A Langendijk
Journal:  Ann Oncol       Date:  2012-04-06       Impact factor: 32.976

9.  Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Authors:  Yoann Pointreau; Pascal Garaud; Sophie Chapet; Christian Sire; Claude Tuchais; Jacques Tortochaux; Sandrine Faivre; Stephane Guerrif; Marc Alfonsi; Gilles Calais
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

10.  Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.

Authors:  Allen S Ho; Sungjin Kim; Mourad Tighiouart; Cynthia Gudino; Alain Mita; Kevin S Scher; Anna Laury; Ravi Prasad; Stephen L Shiao; Jennifer E Van Eyk; Zachary S Zumsteg
Journal:  J Clin Oncol       Date:  2017-09-07       Impact factor: 50.717

View more
  37 in total

1.  Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.

Authors:  Z S Zumsteg; M Luu; S Kim; M Tighiouart; A Mita; K S Scher; D J Lu; S L Shiao; J Mallen-St Clair; A S Ho
Journal:  Ann Oncol       Date:  2019-01-01       Impact factor: 32.976

2.  Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.

Authors:  Xiaokai Mo; Xiangjun Wu; Di Dong; Baoliang Guo; Changhong Liang; Xiaoning Luo; Bin Zhang; Lu Zhang; Yuhao Dong; Zhouyang Lian; Jing Liu; Shufang Pei; Wenhui Huang; Fusheng Ouyang; Jie Tian; Shuixing Zhang
Journal:  Eur Radiol       Date:  2019-10-30       Impact factor: 5.315

3.  Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary.

Authors:  Won Ki Cho; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-19       Impact factor: 4.553

4.  Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer.

Authors:  Yeonjoo Choi; Manal Bin-Manie; Jong-Lyel Roh; Kyung-Ja Cho; Yoon Se Lee; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-27       Impact factor: 4.553

5.  Nodal grouping in nasopharyngeal carcinoma: prognostic significance, N classification, and a marker for the identification of candidates for induction chemotherapy.

Authors:  Yifei Liu; Shenghuan Chen; Annan Dong; Fei Ai; Tingting Quan; Chunyan Cui; Jian Zhou; Shaobo Liang; Jiamin Wang; Shunxin Wang; Ling Hua; Shuoyu Xu; Mingyuan Chen; Ying Sun; Haojiang Li; Lizhi Liu
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

6.  Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy.

Authors:  Xiaobin Liu; Chuanqi Sun; Miaomiao Long; Yining Yang; Peng Lin; Shuang Xia; Wen Shen
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-25       Impact factor: 2.503

7.  Oncological Analysis and Surgical Outcomes in Postcricoid Carcinoma: A 14 Years Retrospective Study.

Authors:  Chun Chen; Lei Hang; Yupeng Liu; Jin Xie; Jun Yang
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

8.  Development of a novel salivary gland cancer lymph node staging system.

Authors:  Katri Aro; Allen S Ho; Michael Luu; Sungjin Kim; Mourad Tighiouart; Jon Mallen-St Clair; Emi J Yoshida; Stephen L Shiao; Ilmo Leivo; Zachary S Zumsteg
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

9.  Identification of core miRNA prognostic markers in patients with laryngeal cancer using bioinformatics analysis.

Authors:  Guan-Jiang Huang; Bei-Bei Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-12       Impact factor: 2.503

10.  Nodal characteristics associated with adverse prognosis in oral cavity cancer are linked to host immune status.

Authors:  Cristina Valero; Daniella K Zanoni; Anjali Pillai; Bin Xu; Nora Katabi; Ronald A Ghossein; Ian Ganly; Luc G T Morris; Jatin P Shah; Richard J Wong; Snehal G Patel
Journal:  J Surg Oncol       Date:  2020-09-24       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.